Tag: lung cancer

Featured Health & Pharmaceuticals

Actavis launches Gemcitabine on patent expiry in EU markets

March 13, 20092 min read

The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone

Actavis, bladder cancer, breast cancer, EU, Gemcitabine, hospital business, lung cancer, oncology treatment, pancreatic cancer, patent expiry, treatment of cancer

You May Have Missed

Business Environment Retail & Services

Land-Based Salmon Farming in Iceland Sets New Benchmark for Premium Atlantic Salmon in EU Market

April 20, 2026

Environment Retail & Services Travel & Leisure

Car Rental in Iceland: Hertz Iceland Expands Electric Vehicle Fleet for Sustainable Travel

March 30, 2026March 30, 2026

Retail & Services Travel & Leisure

Iceland Road Tax 2026: What It Means for Visitors Renting a Car in Iceland

March 4, 2026

Featured Health & Pharmaceuticals

Mental Wellness Platform Attracts Fulbright Canada President and Leading Researchers to Advisory Board Ahead of Global Launch

February 12, 2026February 12, 2026